Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels |
---|---|---|---|---|
1 | ||||
Pruritus | Pruritus | 16.1% - 27.6% | x | |
Skin disorder | Unspecified disorder of skin and subcutaneous tissue | 16.1% - 27.6% | x | |
Hypotension | Hypotension | 2.19% - 6.71% | x | |
Angiopathy | Angiopathy | 2.19% - 6.71% | x | |
Mediastinal disorder | Mediastinal disorder | 0.813% - 10.7% | x | |
Hypoxia | Hypoxemia | 0.813% - 10.7% | x | |
Apnoea | Apnoea | x | ||
Cough | Cough | x | ||
Gastrointestinal disorder | Gastrointestinal disorder | x | ||
Headache | Headache | x | ||
Nausea | Nausea | x | ||
Nervous system disorder | Nervous system disorder | x | ||
Paraesthesia | Paraesthesia | x | ||
Tingling sensation | x | |||
Vomiting | Vomiting | x | ||
Respiratory depression | Respiratory depression | x | ||
Pulmonary function test decreased | Respiratory depression | x | ||
Pain | Stinging | x | ||
Ventricular tachycardia | Non-sustained ventricular tachycardia | x | ||
Hepatic failure | Hepatic insufficiency | x | ||
Procedural pain | Procedural pain | 0% - 2.01% | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Acute myeloid leukaemia | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |